Literature DB >> 7834216

Muscarinic (M1) receptor-mediated inhibition of K(+)-evoked [3H]-noradrenaline release from human neuroblastoma (SH-SY5Y) cells via inhibition of L- and N-type Ca2+ channels.

R L McDonald1, P F Vaughan, C Peers.   

Abstract

1. Human neuroblastoma (SH-SY5Y) cells were preincubated with [3H]-noradrenaline ([3H]-NA) in the presence of 0.2 mM pargyline to examine the modulation of K(+)-evoked [3H]-NA release by muscarinic agonists. 2. Release of [3H]-NA evoked by 4 min exposure to 100 mM K+ could be partially inhibited by 5 microM nifedipine and partially inhibited by 100 nM omega-conotoxin GVIA (omega-CgTx). When nifedipine and omega-CgTx were added together, evoked release was inhibited by approximately 93%. 3. K(+)-evoked [3H]-NA release was inhibited by > 90% by pretreatment of cells for 2 min with muscarine, carbachol or oxotremorine methiodide (each at 300 microM). For muscarine, inhibition of evoked release was both time- and concentration-dependent and was reversible. Muscarine also inhibited [3H]-NA release evoked by veratridine (28 microM) and replacement of extracellular Ca2+ with Ba2+, but not that evoked by the Ca2+ ionophore, A23187 (19 microM). 4. Residual K(+)-evoked [3H]-NA release measured in the presence of either nifedipine (5 microM) or omega-CgTx (100 nM) was inhibited by muscarine with a similar potency as release evoked in the absence of either Ca2+ channel blocker. Pretreatment of cells for 16-24 h with pertussis toxin (200 ng ml-1) did not affect K(+)-evoked release per se or the ability of muscarine to inhibit such release. 5. Muscarinic inhibition of K(+)-evoked [3H]-NA release was potently antagonized by pirenzepine (pA2 8.14) and by hexahydrosiladiphenidol (pA2 9.03), suggesting the involvement of an M1 receptor. 6. Our results demonstrate that 100 mM K+-evoked release of [3H]-NA from the human neuroblastoma is mediated by activation of both L- and N-type Ca2+ channels. Activation of muscarinic Ml receptors can inhibit release via a pertussis toxin-insensitive mechanism which involves non-selective inhibition of L- and N-type Ca2+ channels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7834216      PMCID: PMC1510124          DOI: 10.1111/j.1476-5381.1994.tb17035.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

Review 1.  G proteins.

Authors:  J R Hepler; A G Gilman
Journal:  Trends Biochem Sci       Date:  1992-10       Impact factor: 13.807

Review 2.  Modulation of vertebrate neuronal calcium channels by transmitters.

Authors:  R Anwyl
Journal:  Brain Res Brain Res Rev       Date:  1991 Sep-Dec

Review 3.  Two high-threshold Ca2+ channels contribute Ca2+ for depolarization-secretion coupling in the mammalian neurohypophysis.

Authors:  M C Nowycky
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

Review 4.  Pharmacology and second messenger interactions of cloned muscarinic receptors.

Authors:  M H Richards
Journal:  Biochem Pharmacol       Date:  1991-10-09       Impact factor: 5.858

5.  Two types of high voltage-activated calcium channels in SH-SY5Y human neuroblastoma cells.

Authors:  E Reuveny; T Narahashi
Journal:  Brain Res       Date:  1993-02-12       Impact factor: 3.252

6.  Neurotransmitters inhibit the omega-conotoxin-sensitive component of Ca current in neuroblastoma x glioma hybrid (NG 108-15) cells, not the nifedipine-sensitive component.

Authors:  M P Caulfield; J Robbins; D A Brown
Journal:  Pflugers Arch       Date:  1992-04       Impact factor: 3.657

7.  Chronic exposure to morphine does not induce dependence at the level of the calcium channel current in human SH-SY5Y cells.

Authors:  C Kennedy; G Henderson
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

8.  Enhancement of N- and L-type calcium channel currents by protein kinase C in frog sympathetic neurons.

Authors:  J Yang; R W Tsien
Journal:  Neuron       Date:  1993-02       Impact factor: 17.173

9.  Evidence for M1 muscarinic cholinoceptors mediating facilitation of noradrenaline release in guinea-pig carotid artery.

Authors:  M A Casado; J Marín; M Salaices
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

10.  The epithelial phenotype of human neuroblastoma cells express bradykinin, endothelin, and angiotensin II receptors that stimulate phosphoinositide hydrolysis.

Authors:  Y Ogino; T Costa
Journal:  J Neurochem       Date:  1992-01       Impact factor: 5.372

View more
  5 in total

Review 1.  The regulation of neurotransmitter secretion by protein kinase C.

Authors:  P F Vaughan; J H Walker; C Peers
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

2.  Competition between Li+ and Mg2+ in neuroblastoma SH-SY5Y cells: a fluorescence and 31P NMR study.

Authors:  L Amari; B Layden; J Nikolakopoulos; Q Rong; D Mota de Freitas; G Baltazar; M M Castro; C F Geraldes
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

3.  The Na+-Ca2+ exchange inhibitor KB-R7943 inhibits high K+-induced increases in intracellular Ca2+ concentration and [3H]noradrenaline release in the human neuroblastoma SH-SY5Y.

Authors:  H Nakamura; Y Kawasaki; N Arakawa; M Saeki; S Maeda; Y Koyama; A Baba; T Matsuda
Journal:  Neurochem Res       Date:  2000-03       Impact factor: 3.996

4.  Enhancement of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by phorbol esters with and without activation of protein kinase C.

Authors:  H L Reeve; P F Vaughan; C Peers
Journal:  Pflugers Arch       Date:  1995-03       Impact factor: 3.657

5.  Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy.

Authors:  Ricardo Capone; Felipe Garcia Quiroz; Panchika Prangkio; Inderjeet Saluja; Anna M Sauer; Mahealani R Bautista; Raymond S Turner; Jerry Yang; Michael Mayer
Journal:  Neurotox Res       Date:  2009-03-19       Impact factor: 3.911

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.